PPIDT00433
Drug Information
| Name | Evinacumab |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB15354 |
| Type | biotech |
| Indication | Evinacumab is indicated, as an adjunct with other lipid-lowering therapies, for the treatment of familial homozygous hypercholesterolemia (HoFH) in patients 5 years of age and older.[L45638,L49951,L49961] |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, solution, concentrate | Intravenous |
150 MG/ML
|
| Injection, solution, concentrate | Intravenous |
150 mg/1mL
|
| Solution | Intravenous |
150 mg / mL
|